Phillips-Medisize today launched the third generation of its connected health platform, designed to serve the pharmaceutical and medical device industries.
The Wisconsin-based company touted that its system was used in the first drug-device product approved by the FDA to track medication adherence.
When combined with drug-delivery devices, connected health programs can help companies, doctors and patients track medication usage and improve disease management, according to Phillips-Medisize. The company said that its platform features a secure and scalable medical device data system that uses analytics to provide insights from electronic medical records, pharmacies and other IoT devices.
“Phillips-Medisize is a leader in connected health systems for medicine currently on the market, supporting patients daily across the globe. This new, advanced connected health platform builds on our deep knowledge and experience,” CTO Bill Welch said in prepared remarks.
“For us, connected health is a strategy for better serving our customers and their patients, not a buzzword. We are unmatched in the industry with our global innovation, development and manufacturing capabilities to create end-to-end systems,” Welch added.
